Visceral leishmaniasis as a cause of anemia in HIV-infected patients

被引：4
|
作者：
Cascio, A
Iaria, C
Antinori, S
机构：
[1] Univ Messina, Clin Malattie Infett, Dipartimento Patol Umana, I-98125 Messina, Italy
[2] Univ Messina, AILMI, Scuola Specializzaz Malattie Infett, I-98125 Messina, Italy
[3] Univ Milan, Ist Mallattie Infett & Trop, Milan, Italy
来源：
CLINICAL INFECTIOUS DISEASES | 2004年 / 39卷 / 07期
关键词：
D O I：
10.1086/424452
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
下载
收藏
页码：1088 / 1089
页数：2
相关论文
共 50 条
  • [31] Comment on: Efficacy of liposomal amphotericin B for secondary prophylaxis of visceral leishmaniasis in HIV-infected patients
    Collazos, Julio
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 61 (02) : 466 - 467
  • [32] Ultrasensitive Real-Time PCR for the Clinical Management of Visceral Leishmaniasis in HIV-Infected Patients
    Molina, Israel
    Fisa, Roser
    Riera, Cristina
    Falco, Vicenc
    Elizalde, Aleix
    Salvador, Fernando
    Crespo, Manuel
    Curran, Adrian
    Lopez-Chejade, Paulo
    Tebar, Silvia
    Perez-Hoyos, Santiago
    Ribera, Esteban
    Pahissa, Albert
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2013, 89 (01): : 105 - 110
  • [33] VISCERAL LEISHMANIASIS IN AN HIV-INFECTED PATIENT - CLINICAL-FEATURES AND RESPONSE TO TREATMENT
    FENSKE, S
    STELLBRINK, HJ
    ALBRECHT, H
    GRETEN, H
    KLINISCHE WOCHENSCHRIFT, 1991, 69 (17): : 793 - 796
  • [34] Disseminated Penicillium marneffei infection suggesting visceral leishmaniasis in an HIV-infected patient
    Rosenthal, E
    Marty, P
    Ferrero, C
    Le Fichoux, Y
    Cassuto, JP
    PRESSE MEDICALE, 2000, 29 (07): : 363 - 364
  • [35] VISCERAL LEISHMANIASIS IN PATIENTS INFECTED WITH HUMAN IMMUNODEFICIENCY VIRUS (HIV)
    BERENGUER, J
    MORENO, S
    CERCENADO, E
    DEQUIROS, JCLB
    DELAFUENTE, AG
    BOUZA, E
    ANNALS OF INTERNAL MEDICINE, 1989, 111 (02) : 129 - 132
  • [36] Exploring prognosis in chronic relapsing visceral leishmaniasis among HIV-infected patients: Circulating Leishmania DNA
    Cota, Glaucia Fernandes
    de Sousa, Marcos Roberto
    Machado de Assis, Talia Santana
    Pinto, Bruna Fernandes
    Rabello, Ana
    ACTA TROPICA, 2017, 172 : 186 - 191
  • [37] Amphotericin B lipid complex versus no treatment in the secondary prophylaxis of visceral leishmaniasis in HIV-infected patients
    López-Vélez, R
    Videla, S
    Márquez, M
    Boix, V
    Jiménez-Mejías, ME
    Górgolas, M
    Arribas, JR
    Salas, A
    Laguna, F
    Sust, M
    Cañavate, C
    Alvar, J
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 53 (03) : 540 - 543
  • [38] INDIRECT XENODIAGNOSIS OF VISCERAL LEISHMANIASIS IN 10 HIV-INFECTED PATIENTS USING COLONIZED PHLEBOTOMUS-PERNICIOSUS
    MOLINA, R
    CANAVATE, C
    CERCENADO, E
    LAGUNA, F
    LOPEZVELEZ, R
    ALVAR, J
    AIDS, 1994, 8 (02) : 277 - 279
  • [39] Highly active antiretroviral therapy (HAART) modifies the incidence and outcome of visceral leishmaniasis in HIV-infected patients
    Tortajada, C
    Pérez-Cuevas, B
    Moreno, A
    Martínez, E
    Mallolas, J
    García, F
    Valls, E
    Miró, JM
    De Lazzari, E
    Gatell, JM
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2002, 30 (03) : 364 - 366
  • [40] Treatment of visceral leishmaniasis in HIV-infected patients:: a randomized trial comparing meglumine antimoniate with amphotericin B
    Laguna, F
    López-Vélez, R
    Pulido, F
    Salas, A
    Torre-Cisneros, J
    Torres, E
    Medrano, FJ
    Sanz, J
    Picó, G
    Gómez-Rodrigo, J
    Pasquau, J
    Alvar, J
    AIDS, 1999, 13 (09) : 1063 - 1069
12345